With 1.07 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.58 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.0199 whereas the lowest price it dropped to was $0.87. The 52-week range on BDRX shows that it touched its highest point at $30.00 and its lowest point at $0.78 during that stretch. It currently has a 1-year price target of $18.00. Beta for the stock currently stands at 0.98.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BDRX was up-trending over the past week, with a rise of 1.02%, but this was down by -20.01% over a month. Three-month performance dropped to -50.29% while six-month performance fell -80.53%. The stock lost -78.27% in the past year, while it has lost -96.74% so far this year. A look at the trailing 12-month EPS for BDRX yields -17.42 with Next year EPS estimates of -0.00. For the next quarter, that number is -0.00. This implies an EPS growth rate of 59.49% for this year and 75.05% for next year.
Float and Shares Shorts:
On 2025-06-13, short shares totaled 0.18 million, which was 352.0 higher than short shares on 1747267200. In addition to Mr. Stephen Anthony Stamp as the firm’s CEO, CFO, Company Secretary & Director, Dr. Daniel Palmer MBA, Ph.D. serves as its Vice President of Technology.
Institutional Ownership:
Through their ownership of 0.07699 of BDRX’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With BDRX analysts setting a high price target of 18.177553 and a low target of 18.177553, the average target price over the next 12 months is 18.177553. Based on these targets, BDRX could surge 1965.63% to reach the target high and rise by 1965.63% to reach the target low. Reaching the average price target will result in a growth of 1965.63% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.00052500213 being high and -$0.00052500213 being low. For BDRX, this leads to a yearly average estimate of -$0.00052500213.
